ES2165485T3 - Compuestos de o-carbamoil-(d)-fenilalaninol y procedimiento para preparar los mismos. - Google Patents

Compuestos de o-carbamoil-(d)-fenilalaninol y procedimiento para preparar los mismos.

Info

Publication number
ES2165485T3
ES2165485T3 ES96901562T ES96901562T ES2165485T3 ES 2165485 T3 ES2165485 T3 ES 2165485T3 ES 96901562 T ES96901562 T ES 96901562T ES 96901562 T ES96901562 T ES 96901562T ES 2165485 T3 ES2165485 T3 ES 2165485T3
Authority
ES
Spain
Prior art keywords
same
sup
carbamoil
prepare
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901562T
Other languages
English (en)
Inventor
Yong Moon Choi
Dong Il Han
Yong Kil Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Corp
Original Assignee
SK Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Corp filed Critical SK Corp
Application granted granted Critical
Publication of ES2165485T3 publication Critical patent/ES2165485T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Abstract

LA PRESENTE INVENCION TRATA DE UN COMPUESTO DE O OIL (D) (V) Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO, PARA TRATAR ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL, EN LA CUAL R{SUP,1} Y R{SUP,2} PUEDEN SER LOS MISMOS O DIFERENTES, Y SE SELECCIONAN INDEPENDIENTEMENTE ENTRE EL GRUPO FORMADO POR HIDROGENO, ALQUILO INFERIOR QUE CONTIENE DE 1 A 8 ATOMOS DE CARBONO, Y COMPUESTOS CICLICOS ALIFATICOS DE 5 A 7 ESLABONES QUE PUEDEN INCLUIR NO MAS DE DOS ATOMOS DE NITROGENO U OXIGENO NO CONECTADOS DIRECTAMENTE, VARIANDO EL NUMERO TOTAL DE ATOMOS DE CARBONO DE R{SUP,1} Y R{SUP,2} DESDE 0 A 16.
ES96901562T 1995-02-11 1996-02-08 Compuestos de o-carbamoil-(d)-fenilalaninol y procedimiento para preparar los mismos. Expired - Lifetime ES2165485T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950002543A KR0173862B1 (ko) 1995-02-11 1995-02-11 O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법

Publications (1)

Publication Number Publication Date
ES2165485T3 true ES2165485T3 (es) 2002-03-16

Family

ID=19408007

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901562T Expired - Lifetime ES2165485T3 (es) 1995-02-11 1996-02-08 Compuestos de o-carbamoil-(d)-fenilalaninol y procedimiento para preparar los mismos.

Country Status (11)

Country Link
US (1) US5705640C1 (es)
EP (1) EP0815074B1 (es)
JP (1) JP3828574B2 (es)
KR (1) KR0173862B1 (es)
CN (1) CN1070846C (es)
CA (1) CA2212326C (es)
DE (1) DE69615668T2 (es)
DK (1) DK0815074T3 (es)
ES (1) ES2165485T3 (es)
PT (1) PT815074E (es)
WO (1) WO1996024577A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0173863B1 (ko) * 1995-04-10 1999-04-01 조규향 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법
PT873308E (pt) * 1996-10-10 2002-06-28 Sk Corp Compostos de o-carbamoil-fenilalaninol seus sais farmaceuticamente uteis e processo para a preparacao dos mesmos
BRPI0518233A2 (pt) * 2004-10-28 2008-11-11 Sk Corp terapia adjunta para depressço
PL1890684T3 (pl) 2005-06-08 2014-05-30 Sk Biopharmaceuticals Co Ltd Leczenie zaburzeń snu i czuwania
KR101335942B1 (ko) 2005-06-22 2013-12-04 에스케이바이오팜 주식회사 성기능 장애의 치료
CN101557804A (zh) * 2006-10-13 2009-10-14 詹森药业有限公司 氨基甲酸苯基烷基氨基酯组合物
US8642772B2 (en) 2008-10-14 2014-02-04 Sk Biopharmaceuticals Co., Ltd. Piperidine compounds, pharmaceutical composition comprising the same and its use
IN2012DN00624A (es) * 2009-06-22 2015-06-12 Sk Biopharmaceuticals Co Ltd
US8232315B2 (en) * 2009-06-26 2012-07-31 Sk Biopharmaceuticals Co., Ltd. Methods for treating drug addiction and improving addiction-related behavior
JP5901528B2 (ja) 2009-11-06 2016-04-13 エスケー バイオファーマスティカルズ カンパニー リミテッド 線維筋痛症候群の治療方法
JP5836280B2 (ja) * 2009-11-06 2015-12-24 エスケー バイオファーマスティカルズ カンパニー リミテッド 注意欠陥／多動性障害（ａｄｈｄ）の治療方法
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
KR102192554B1 (ko) 2013-03-13 2020-12-18 에스케이바이오팜 주식회사 탈력발작의 치료
KR102309836B1 (ko) 2013-07-18 2021-10-12 에스케이바이오팜 주식회사 비만의 치료
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds
TWI655179B (zh) 2014-02-28 2019-04-01 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物
US10829443B2 (en) 2016-09-06 2020-11-10 Jazz Pharmaceuticals Ireland Limited Solvate form of (R)-2-amino-3-phenylpropyl carbamate
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
ES2964943T3 (es) 2016-10-06 2024-04-10 Axsome Malta Ltd Compuestos de carbamoilfenilalaninol para uso médico
KR20200016889A (ko) 2017-06-02 2020-02-17 재즈 파마슈티칼즈 아일랜드 리미티드 과다 졸림증을 치료하기 위한 방법 및 조성물
CN111094238B (zh) 2017-07-31 2023-06-09 杰资制药爱尔兰有限公司 氨基甲酰基苯丙氨醇类似物及其用途
CN110655500B (zh) * 2018-06-28 2020-12-08 浙江京新药业股份有限公司 氨基甲酸酯衍生物及其制备方法和用途
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function
KR102390194B1 (ko) 2020-08-03 2022-04-25 셀라이온바이오메드 주식회사 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물
WO2023091921A1 (en) * 2021-11-16 2023-05-25 Axsome Malta Ltd. Methods and compositions for treating cognitive impairment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470277A1 (de) * 1963-04-18 1969-05-29 Siegfried Ag Verfahren zur Herstellung von spasmolytische und tremolytische Eigenschaften aufweisenden Carbaminaten
FR8411M (es) * 1968-12-31 1971-03-31
AT387572B (de) * 1983-05-20 1989-02-10 Ferrosan Ab Verfahren zur herstellung von neuen 4-(4,4-bis-(p-fluorphenyl)-butyl)-1-carbophenox -piperazinen und von 1-piperazincarboxamiden
KR100197892B1 (ko) * 1994-09-09 1999-06-15 남창우 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법

Also Published As

Publication number Publication date
CA2212326A1 (en) 1996-08-15
DK0815074T3 (da) 2002-01-28
DE69615668D1 (de) 2001-11-08
CN1173863A (zh) 1998-02-18
JPH11501617A (ja) 1999-02-09
KR0173862B1 (ko) 1999-04-01
EP0815074B1 (en) 2001-10-04
US5705640C1 (en) 2001-03-20
KR960031427A (ko) 1996-09-17
CA2212326C (en) 2008-12-23
PT815074E (pt) 2002-03-28
JP3828574B2 (ja) 2006-10-04
DE69615668T2 (de) 2002-07-11
EP0815074A1 (en) 1998-01-07
US5705640A (en) 1998-01-06
CN1070846C (zh) 2001-09-12
WO1996024577A1 (en) 1996-08-15

Similar Documents

Publication Publication Date Title
ES2165485T3 (es) Compuestos de o-carbamoil-(d)-fenilalaninol y procedimiento para preparar los mismos.
ES2185999T3 (es) Derivados de quinazolina y composiciones farmaceuticas que los contienen.
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
SV1998000029A (es) Compuestos de pirazina ref. pg3186
ES2164889T3 (es) Semicarbazonas con actividad sobre el snc y preparados farmaceuticos a base de las mismas.
NO961687L (no) Nye (R)-5-karbamoyl-8-fluor-3-N,N-disubstituerte-amino-3,4-dihydro-2H-1-benzopyraner
DK46789A (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
ES2124612T3 (es) Dihidrodibenzo(b,f)azepinas, substituidas, metodo para su preparacion, su utilizacion en el tratamiento de diversos trastornos del sistema nervioso central y composiciones farmaceuticas que las contienen.
ES2181902T3 (es) Derivados de 4,5-diaril-oxazol.
BR9810841A (pt) Inibidores de metaloprotease alicìclicos
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
ES2133714T3 (es) Compuestos heterociclicos para el tratamiento de trastornos del snc y cardiovasculares.
BR9713186A (pt) Inibidores de metaloprotease 1,3-diheterocìclicos
ES2179935T3 (es) Derivados de polisacaridos fotoquimicamente reticulados como soportes para la separacion cromatografica de enantiomeros.
NO983636D0 (no) Fremgangsmåte for behandling av trekninger og sykdomstilstander i sentralnervesystemet ved anvendelse av optisk rent (+) norcisaprid
ES2170878T3 (es) Compuestos de o-carbamoil-fenilalaninol y sus sales farmaceuticamente utiles.
ES2072263T3 (es) Derivados de 4-aminopiridina.
ES2145379T3 (es) Uso de dioxabiciclo(3.3.0)octanos para el tratamiento y la prevencion de la apoplejia cerebral.
MX9304524A (es) Nuevos derivados de indol y composiciones que los contienen.
MX163574B (es) Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido
ES2189956T3 (es) Derivados de quinolina, procedimientos para su preparacion y su uso como medicamentos.
AR019947A1 (es) Metodo para tratar o prevenir trastornos causados por disfunciones de la motilidad intestinal en seres humanos y composiciones farmaceuticas de aplicacionen dicho metodo
GT199800203A (es) Compuestos de triazina.
NO307364B1 (no) Anvendelse av melatoninderivater
ES2099865T3 (es) Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 815074

Country of ref document: ES